Cash-Rich NicOx Surges on $31M Altacor Acquisition Deal
By Cormac Sheridan
Wednesday, March 28, 2012
Shares in NicOx SA surged almost 35 percent last week on news that the company had taken its first concrete step toward becoming a late-stage development and commercial player in opthalmology by entering a cash-and-shares acquisition agreement with Altacor Ltd. that could be worth as much as £19.5 million (US$30.9 million).
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.